Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04143100 · ClinicalTrials.gov registry record
Anxiety and Symptom Burden in Hemodialysis Patients
A clinical trial, sponsored by The Rogosin Institute.
- Completed
- Registry status
- 100
- Enrollment target
NCT04143100 is a clinical trial that has completed, run by The Rogosin Institute. The registered enrollment target is 100 participants.
The verdict
NCT04143100 has completed, sponsored by The Rogosin Institute.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Anxiety has been identified as a prevalent and significant co-morbid condition in patients with End Stage Renal Disease (ESRD) being treated with hemodialysis. In particular, anxious sensitivity to symptoms commonly experienced by dialysis patients may lead patients to prematurely terminate their dialysis sessions and may have consequences on their dialysis adequacy and overall quality of life. The proposed study will examine the relationships between anxiety, depression, quality of life, symptom burden and dialysis prescription adherence. The primary regression analyses will be used to predict the influence of anxiety and depression (independently and together) on measures of adherence behaviors.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-08-30 |
| Est. Completion | 2020-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04143100
The ClinicalTrials.gov registry entry for NCT04143100 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Rogosin Institute, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT04143100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04143100 about?
NCT04143100 is a clinical study titled "Anxiety and Symptom Burden in Hemodialysis Patients". Anxiety has been identified as a prevalent and significant co-morbid condition in patients with End Stage Renal Disease (ESRD) being treated with hemodialysis. In particular, anxious sensitivity to symptoms commonly experienced by dialysis patients may lead patients to prematurely terminate their di...
What is the current status of trial NCT04143100?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2019-08-30. Estimated completion is 2020-12-31.
What interventions are being tested in trial NCT04143100?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT04143100?
This trial is sponsored by The Rogosin Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.